EP 3512502 A1 20190724 - STABLE PHARMACEUTICAL FOAM
Title (en)
STABLE PHARMACEUTICAL FOAM
Title (de)
STABILER PHARMAZEUTISCHER SCHAUM
Title (fr)
MOUSSE PHARMACEUTIQUE STABLE
Publication
Application
Priority
- IL 24781016 A 20160914
- US 201662394371 P 20160914
- IL 2017000007 W 20170911
Abstract (en)
[origin: WO2018051325A1] Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.
IPC 8 full level
A61K 9/12 (2006.01); A61K 47/42 (2017.01); A61P 17/02 (2006.01)
CPC (source: EP IL KR)
A61K 9/122 (2013.01 - IL KR); A61K 38/01 (2013.01 - EP IL); A61K 38/014 (2013.01 - IL KR); A61K 38/363 (2013.01 - IL KR); A61K 38/4833 (2013.01 - IL KR); A61L 26/0028 (2013.01 - EP IL KR); A61L 26/0042 (2013.01 - EP IL KR); A61L 26/0047 (2013.01 - EP IL KR); A61L 26/0085 (2013.01 - EP IL KR); A61P 7/04 (2018.01 - EP IL KR); A61P 17/02 (2018.01 - EP IL KR); A61L 2400/04 (2013.01 - EP IL KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018051325 A1 20180322; AU 2017328480 A1 20190314; CA 3036770 A1 20180322; CN 109789091 A 20190521; EP 3512502 A1 20190724; IL 265252 A 20190530; IL 265252 B1 20230701; IL 265252 B2 20231101; JP 2019526646 A 20190919; JP 7114597 B2 20220808; KR 102656742 B1 20240415; KR 20190054110 A 20190521; MA 46239 A 20190724
DOCDB simple family (application)
IL 2017000007 W 20170911; AU 2017328480 A 20170911; CA 3036770 A 20170911; CN 201780056569 A 20170911; EP 17780529 A 20170911; IL 26525219 A 20190310; JP 2019536003 A 20170911; KR 20197010499 A 20170911; MA 46239 A 20170911